Healthcare -
Biotechnology - NASDAQ - US
$ 6.195
-13.2 %
$ 974 M
Market Cap
-4.8
P/E
OCUL - REVENUE
Revenue OCUL - Ocular Therapeutix, Inc.
58.4 M
LAST VALUE
15.88%
2 YEAR CAGR
96.60%
5 YEAR CAGR
0.00%
10 YEAR CAGR